The use of positive airway pressure therapy for treatment of resistant hypertension

References

• Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. Hypertension. 2008;51(6):1403–1419.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Lapenna D, Bucci A, et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens. 2005;18:1422–1428.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Macca G, Sampieri L, et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens. 2001;19:2063–2070.
   PubMed Web of Science ®Google Scholar
• Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58:811–817.
   PubMed Web of Science ®Google Scholar
• Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens. 2001;19:2271–2277.
   PubMed Web of Science ®Google Scholar
• Gonzaga CC, Gaddam KK, Ahmed MI, et al. Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension. J Clinic Sleep Med: JCSM: Official Publ Am Acad Sleep Med. 2010;6:363–368.
   PubMed Web of Science ®Google Scholar
• Gonçalves SC, Martinez D, Gus M, et al. Obstructive sleep apnea and resistant hypertension: a case-control study. Chest. 2007;132:1858–1862.
   PubMed Web of Science ®Google Scholar
• Min HJ, Cho YJ, Kim CH, et al. Clinical features of obstructive sleep apnea that determine its high prevalence in resistant hypertension. Yonsei Med J. 2015;56:1258–1265.
   PubMed Web of Science ®Google Scholar
• Elias RM, Castro MC, De Queiroz EL, et al. Obstructive sleep apnea in patients on conventional and short daily hemodialysis. Am J Nephrol. 2009;29:493–500.
   PubMed Web of Science ®Google Scholar
• Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36:286–290.
   PubMed Web of Science ®Google Scholar
• Grote L, Hedner J, Peter JH. Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension. J Hypertens. 2000;18:679–685.
   PubMed Web of Science ®Google Scholar
• Lavie P, Silverberg D, Oksenberg A, et al. Obstructive sleep apnea and hypertension: from correlative to causative relationship. J Clin Hypertens. 2001;3:296–301.
   Google Scholar
• Faulx MD, Storfer-Isser A, Kirchner HL, et al. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep. 2007;30:923–929.
   PubMed Web of Science ®Google Scholar
• Drager LF, Bortolotto LA, Krieger EM, et al. Additive effects of obstructive sleep apnea and hypertension on early markers of carotid atherosclerosis. Hypertension. 2009;53:64–69.
   PubMed Web of Science ®Google Scholar
• Somers VK, Dyken ME, Clary MP, et al. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897–1904.
   PubMed Web of Science ®Google Scholar
• Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA. 2000;283:1829–1836.
   PubMed Web of Science ®Google Scholar
• Peppard PE, Young T, Palta M, et al. Prospective study of the association between sleep-disordered breathing and hypertension. New Eng J Med. 2000;342:1378–1384.
   PubMed Web of Science ®Google Scholar
• Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation. 2010;121:1014–1021.
   PubMed Web of Science ®Google Scholar
• Xie X, Pan L, Ren D, et al. Effects of continuous positive airway pressure therapy on systemic inflammation in obstructive sleep apnea: a meta-analysis. Sleep Med. 2013;14:1139–1150.
   PubMed Web of Science ®Google Scholar
• Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation. 1999;100:2332–2335.
   PubMed Web of Science ®Google Scholar
• Patwardhan AA, Larson MG, Levy D, et al. Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample. Sleep. 2006;29:1301–1306.
   PubMed Web of Science ®Google Scholar
• Gangwisch JE, Heymsfield SB, Boden-Albala B, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47:833–839.
   PubMed Web of Science ®Google Scholar
• Ruttanaumpawan P, Nopmaneejumruslers C, Logan AG, et al. Association between refractory hypertension and obstructive sleep apnea. J Hypertens. 2009;27:1439–1445.
   PubMed Web of Science ®Google Scholar
• Lloberes P, Lozano L, Sampol G, et al. Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension. J Sleep Res. 2010;19:597–602.
   PubMed Web of Science ®Google Scholar
• Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007;131:453–459.
   PubMed Web of Science ®Google Scholar
• Gaddam K, Pimenta E, Thomas SJ, et al. Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24:532–537.
   PubMed Web of Science ®Google Scholar
• Friedman O, Bradley TD, Ruttanaumpawan P, et al. Independent association of drug-resistant hypertension to reduced sleep duration and efficiency. Am J Hypertens. 2010;23:174–179.
   PubMed Web of Science ®Google Scholar
• Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnoea and aldosterone. J Hum Hypertens. 2012;26:281–287.
   PubMed Web of Science ®Google Scholar
• Svatikova A, Olson LJ, Wolk R, et al. Obstructive sleep apnea and aldosterone. Sleep. 2009;32:1589–1592.
   PubMed Web of Science ®Google Scholar
• Lloberes P, Sampol G, Espinel E, et al. A randomized controlled study of CPAP effect on plasma aldosterone concentration in patients with resistant hypertension and obstructive sleep apnea. J Hypertens. 2014;32:1650–1657. discussion 1657.
   PubMed Web of Science ®Google Scholar
• Barbe F, Duran-Cantolla J, Capote F, et al. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718–726.
   PubMed Web of Science ®Google Scholar
• Drager LF, Pedrosa RP, Diniz PM, et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension. 2011;57:549–555.
   PubMed Web of Science ®Google Scholar
• Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107:68–73.
   PubMed Web of Science ®Google Scholar
• Campos-Rodriguez F, Grilo-Reina A, Perez-Ronchel J, et al. Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest. 2006;129:1459–1467.
   PubMed Web of Science ®Google Scholar
• Campos-Rodriguez F, Perez-Ronchel J, Grilo-Reina A, et al. Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest. 2007;132:1847–1852.
   PubMed Web of Science ®Google Scholar
• Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clinic Sleep Med: JCSM: Official Publ Am Acad Sleep Med. 2009;5:103–107.
   PubMed Web of Science ®Google Scholar
• Logan AG, Tkacova R, Perlikowski SM, et al. Refractory hypertension and sleep apnoea: effect of CPAP on blood pressure and baroreflex. Eur Respir J. 2003;21:241–247.
   PubMed Web of Science ®Google Scholar
• Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens. 2010;28:2161–2168.
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia MA, Capote F, Campos-Rodriguez F, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA. 2013;310:2407–2415.
   PubMed Web of Science ®Google Scholar
• Pedrosa RP, Drager LF, De Paula LK, et al. Effects of OSA treatment on BP in patients with resistant hypertension: a randomized trial. Chest. 2013;144:1487–1494.
   PubMed Web of Science ®Google Scholar
• De Oliveira AC, Martinez D, Massierer D, et al. The antihypertensive effect of positive airway pressure on resistant hypertension of patients with obstructive sleep apnea: a randomized, double-blind, clinical trial. Am J Respir Crit Care Med. 2014;190:345–347.
   PubMed Web of Science ®Google Scholar
• Muxfeldt ES, Margallo V, Costa LM, et al. Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: a randomized controlled trial. Hypertension. 2015;65:736–742.
   PubMed Web of Science ®Google Scholar
• Walia HK, Griffith SD, Foldvary-Schaefer N, et al. Longitudinal effect of continuous positive airway pressure on blood pressure in resistant and non-resistant hypertension in a large clinic-based cohort. Chest. 2015 Jul 30. doi:10.1378/chest.15-0697. [Epub ahead of print].
   PubMedGoogle Scholar
• Fagard RH. Dipping pattern of nocturnal blood pressure in patients with hypertension. Expert Rev Cardiovasc Ther. 2009;7:599–605.
   PubMedGoogle Scholar
• Fagard RH, Thijs L, Staessen JA, et al. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens. 2009;23:645–653.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539–546.
   PubMed Web of Science ®Google Scholar
• Iftikhar IH, Valentine CW, Bittencourt LR, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens. 2014;32:2341–2350. discussion 2350.
   PubMed Web of Science ®Google Scholar
• Varounis C, Katsi V, Kallikazaros IE, et al. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: a systematic review and meta-analysis. Int J Cardiol. 2014;175:195–198.
   PubMed Web of Science ®Google Scholar
• Bazzano LA, Khan Z, Reynolds K, et al. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50:417–423.
   PubMed Web of Science ®Google Scholar
• Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ. 2000;320:479–482.
   PubMed Web of Science ®Google Scholar
• Sanchez-de-la-Torre M, Khalyfa A, Sanchez-de-la-Torre A, et al. Precision medicine in patients with resistant hypertension and obstructive sleep apnea: blood pressure response to continuous positive airway pressure treatment. J Am Coll Cardiol. 2015;66:1023–1032.
   PubMed Web of Science ®Google Scholar
• Dahal K, Kunwar S, Rijal J, et al. The effects of aldosterone antagonists in patients with resistant hypertension: A meta-analysis of randomized and nonrandomized studies. Am J Hypertens. 2015 Nov;28(11):1376–1385.
   PubMed Web of Science ®Google Scholar
• Pepin JL, Tamisier R, Barone-Rochette G, et al. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;182:954–960.
   PubMed Web of Science ®Google Scholar
• Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739–745.
   PubMed Web of Science ®Google Scholar
• Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865–872.
   PubMed Web of Science ®Google Scholar
• Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull. 1994;50:272–298.
   PubMed Web of Science ®Google Scholar
• Malhotra A, White DP. Obstructive sleep apnoea. Lancet. 2002;360:237–245.
   PubMed Web of Science ®Google Scholar
• Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation. 2002;105:2462–2464.
   PubMed Web of Science ®Google Scholar
• Chirinos JA, Gurubhagavatula I, Teff K, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med. 2014;370:2265–2275.
   PubMed Web of Science ®Google Scholar